A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP)

References

• AndrioleVTHaverstockDCChoudhriSH2005Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trialsDrug Saf284435215853445
   PubMed Web of Science ®Google Scholar
• AnzuetoANiedermanMSPearleJ2006Community-acquired pneumonia recovery in the elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacinClin Infect Dis42738116323095
   PubMed Web of Science ®Google Scholar
• ArgirovMRickenGZecherD2005Acute interstitial nephritis associated with moxifloxacin useClin Ther271260316199250
   PubMed Web of Science ®Google Scholar
• ArnoldLMNissenLRNgTM2005Moxifloxacin and warfarin: additional evidence for a clinically relevant interactionPharmacotherapy25904715927911
   PubMed Web of Science ®Google Scholar
• BalfourJALambHM2000Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infectionsDrugs591153910718103
   PubMed Web of Science ®Google Scholar
• BallPStahlmannRKubinR2004Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studiesClin Ther269405015336463
   PubMed Web of Science ®Google Scholar
• BreilhDJougonJDjabaroutiS2003Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-stateJ Chemother155586214998080
   PubMed Web of Science ®Google Scholar
• [BTS] British Thoracic Society Standards of Care CommitteeBTS Guidelines for the management of community-acquired pneumonia in adults2001Thorax5616411120894
   PubMed Web of Science ®Google Scholar
• BurkhardtOKöhnleinTPapT2004Recurrent tendinitis after treatment with two different fluoroquinolonesScand J Infect Dis36315615198194
   PubMed Web of Science ®Google Scholar
• CapitanoBMattoesHMShoreE2004Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adultsChest1259657315006955
   PubMed Web of Science ®Google Scholar
• CunhaBAPneumonia in the elderly2001Clin Microbiol Infect7581811737082
   PubMed Web of Science ®Google Scholar
• DenesEQuel antibiotique pour une pneumonie aiguë communautaire de l’adulte?2006Med Mal Infect367183317092678
   PubMed Web of Science ®Google Scholar
• DrummondMFBeckerDLHuxM2003An economic evaluation of sequential IV/po moxifloxacin therapy compared to IV/po amoxicillin-clavulanate with or without clarithromycin in the treatment of community-acquired pneumoniaChest1245263512907538
   PubMed Web of Science ®Google Scholar
• ElbeDHChangSW2005Moxifloxacin-warfarin interaction: a series of five case reportsAnn Pharmacother39361415632222
   PubMed Web of Science ®Google Scholar
• FerraraAM2005New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistanceInfection3310611415940410
   PubMed Web of Science ®Google Scholar
• FinchRSchürmannDCollinsO2002Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmentAntimicrob Agents Chemother4617465412019085
   PubMed Web of Science ®Google Scholar
• FineMJAubleTEYealyDM1997A prediction rule to identify low-risk patients with community-acquired pneumoniaN Engl J Med336243508995086
   PubMed Web of Science ®Google Scholar
• FogartyCGrossmanCWilliamsJ1999Efficacy and safety of moxifloxacin vs clarithromycin for community-acquired pneumoniaInfect Med1674863
   Web of Science ®Google Scholar
• FogartyCTorresAChoudhriS2005Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumoniaInt J Clin Pract591253916236076
   PubMed Web of Science ®Google Scholar
• HeffelfngerJDDowellSFJorgensenJH2000Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working GroupArch Intern Med1601399140810826451
   PubMedGoogle Scholar
• HoeffkenGMeyerHPWinterJ2001The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumoniaRespir Med955536411453311
   PubMed Web of Science ®Google Scholar
• JanssensJP2005Pneumonia in the elderly (geriatric) populationCurr Opin Pulm Med112263015818184
   PubMed Web of Science ®Google Scholar
• JardimJRRicoGde la RozaC2003A comparison of moxifloxacin and amoxicillin un the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trialArch Bronconeumol393879312975069
   PubMed Web of Science ®Google Scholar
• KatzELarsenLSFogartyCM2004Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapyJ Emerg Med2739540515498622
   PubMed Web of Science ®Google Scholar
• LiebermanDLiebermanD2000Community-acquired pneumonia in the elderly: a practical guide to treatmentDrugs Aging179310510984198
   PubMed Web of Science ®Google Scholar
• LoebM2003Pneumonia in older personsClin Infect Dis371335914583867
   PubMed Web of Science ®Google Scholar
• MandellABartlettJCDowellSF2003Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adultsClin Infect Dis3714053314614663
   PubMed Web of Science ®Google Scholar
• MarrieTJCommunity-acquired pneumonia in the elderly2000Clin Infect Dis3110667811049791
   PubMed Web of Science ®Google Scholar
• MiravitllesM2005Moxifloxacin in respiratory tract infectionsExpert Opin Pharmacother62839315757424
   PubMed Web of Science ®Google Scholar
• MorganrothJDimarcoJPAnzuetoA2005A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumoniaChest128339840616304291
   PubMed Web of Science ®Google Scholar
• NerallaSMeyerKC2004Drug treatment of pneumococcal pneumonia in the elderlyDrugs Aging218516415493950
   PubMed Web of Science ®Google Scholar
• NiedermanMSMandellLAAnzuetoA2001American Thoracic Society: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionAm J Respir Crit Care Med16317304511401897
   PubMed Web of Science ®Google Scholar
• NiedermanMSAhmedQA2003Community-acquired pneumonia in elderly patientsClin Geriatr Med191012012735117
   PubMed Web of Science ®Google Scholar
• PatelTPearlJWilliamsJfor The Community Acquired Pneumonia Study Group2000Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumoniaRespir Med949710510714413
   PubMed Web of Science ®Google Scholar
• PeaFPavanFLugattiE2006Pharmacokinetic and pharmaco-dynamic aspect of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitisClin Pharmacokinet452879516509760
   PubMed Web of Science ®Google Scholar
• PestovaEMillichapJJNoskinGA2000Intracellular targets of moxifloxacin: a comparison with other fluoroquinolonesJ Antimicrob Chemother455839010797078
   PubMed Web of Science ®Google Scholar
• PetitpretzPArvisPMarelM2001Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adultsChest1191859511157603
   PubMed Web of Science ®Google Scholar
• PortierHBrambillaCGarreM2005Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factorsEur J Clin Microbiol Infect Dis243677615944847
   PubMed Web of Science ®Google Scholar
• RajagopalanSYoshikawaTT2001Antimicrobial therapy in the elderlyMed Clin North Am851334711190349
   PubMed Web of Science ®Google Scholar
• Schmidt-IoanasMLodeH2006Treatment of pneumonia in elderly patientsExpert Opin Pharmacother749950716553566
   PubMed Web of Science ®Google Scholar
• SomanAHoneybourneDAndrewsJ1999Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopyJ Antimicrob Chemother44835810590288
   PubMed Web of Science ®Google Scholar
• SotoSLópez-RosésLÁvilaS2002Moxifloxacin-induced acute liver injuryAm J Gastronterol9718534
   PubMed Web of Science ®Google Scholar
• StahlmannRLodeH2003Fluoroquinolones in the elderly: safety considerationsDrugs Aaging20289302
   PubMed Web of Science ®Google Scholar
• TanoECarsOLowdinE2005Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic modelJ Antimicrob Chemother56240215919770
   PubMed Web of Science ®Google Scholar
• TorresAEl-EbiaryMRiquelmeR1999Community-acquired pneumonia in the elderlySemin Respir Infect141738310391411
   PubMedGoogle Scholar
• TorresAMuirJ-FCorrisP2003Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumoniaEur Respir J211354312570122
   PubMed Web of Science ®Google Scholar
• WelteTPetermannWSchurmannDthe MOXIRAPID Study Group2005Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapyClin Infect Dis41169770516288390
   PubMed Web of Science ®Google Scholar
• ZhanelGGEnnisKVercaigneL2002A critical review of the fluoroquinolones. Focus on respiratory tract infectionsDrugs62135911790155
   PubMed Web of Science ®Google Scholar